ICM
JNJ icon

IMS Capital Management’s Johnson & Johnson JNJ Stock Holding History

IMS Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.23M Sell
12,008
-1,613
-12% -$276K 1.03% 24
2025
Q2 		$2.08M Sell
13,621
-6,152
-31% -$946K 0.97% 31
2025
Q1 		$3.28M Buy
19,773
+1,582
+9% +$248K 1.65% 15
2024
Q4 		$2.63M Buy
18,191
+2,823
+18% +$437K 1.22% 22
2024
Q3 		$2.49M Sell
15,368
-60
-0.4% -$9.56K 1.12% 23
2024
Q2 		$2.47M Sell
15,428
-135
-0.9% -$20.1K 1.15% 24
2024
Q1 		$2.46M Sell
15,563
-3
-0% -$478 1.14% 25
2023
Q4 		$2.44M Buy
15,566
+2,440
+19% +$374K 1.2% 22
2023
Q3 		$2.04M Hold
13,126
– – 1.22% 23
2023
Q2 		$2.17M Buy
13,126
+160
+1% +$25.8K 1.21% 21
2023
Q1 		$2.01M Buy
12,966
+107
+0.8% +$17.3K 1.19% 20
2022
Q4 		$2.27M Sell
12,859
-38
-0.3% -$6.56K 1.45% 18
2022
Q3 		$2.11M Buy
12,897
+350
+3% +$59.2K 1.45% 17
2022
Q2 		$2.23M Buy
12,547
+80
+0.6% +$14.3K 1.44% 17
2022
Q1 		$2.21M Buy
12,467
+351
+3% +$59.7K 1.16% 19
2021
Q4 		$2.07M Buy
12,116
+532
+5% +$87.1K 1.07% 19
2021
Q3 		$1.87M Buy
11,584
+285
+3% +$48.6K 1.08% 19
2021
Q2 		$1.86M Sell
11,299
-25
-0.2% -$4.14K 1.1% 18
2021
Q1 		$1.86M Buy
11,324
+425
+4% +$68.8K 1.17% 17
2020
Q4 		$1.72M Sell
10,899
-350
-3% -$51.6K 1.07% 15
2020
Q3 		$1.68M Hold
11,249
– – 1.21% 13
2020
Q2 		$1.58M Sell
11,249
-4,855
-30% -$708K 1.23% 14
2020
Q1 		$2.11M Buy
16,104
+2,125
+15% +$301K 2.15% 7
2019
Q4 		$2.04M Sell
13,979
-210
-1% -$28.5K 1.4% 8
2019
Q3 		$1.84M Buy
14,189
+2,042
+17% +$269K 1.4% 8
2019
Q2 		$1.69M Buy
12,147
+58
+0.5% +$8.03K 1.26% 10
2019
Q1 		$1.69M Sell
12,089
-31
-0.3% -$4.15K 1.38% 9
2018
Q4 		$1.56M Sell
12,120
-1,851
-13% -$258K 1.46% 8
2018
Q3 		$1.93M Sell
13,971
-157
-1% -$20.9K 1.31% 6
2018
Q2 		$1.71M Sell
14,128
-45
-0.3% -$5.61K 1.09% 8
2018
Q1 		$1.98M Hold
14,173
– – 1.23% 5
2017
Q4 		$1.98M Buy
14,173
+41
+0.3% +$5.71K 1.23% 5
2017
Q3 		$1.84M Buy
14,132
+2,045
+17% +$271K 1.18% 7
2017
Q2 		$1.6M Sell
12,087
-129
-1% -$16.5K 1.51% 9
2017
Q1 		$1.52M Buy
12,216
+707
+6% +$84.5K 1.52% 13
2016
Q4 		$1.33M Sell
11,509
-67
-0.6% -$7.74K 1.42% 14
2016
Q3 		$1.37M Sell
11,576
-291
-2% -$35.3K 1.58% 11
2016
Q2 		$1.44M Buy
11,867
+771
+7% +$87.6K 1.68% 11
2016
Q1 		$1.2M Buy
11,096
+835
+8% +$86.4K 1.46% 21
2015
Q4 		$1.05M Sell
10,261
-262
-2% -$26.3K 1.3% 26
2015
Q3 		$982K Buy
10,523
+3,547
+51% +$343K 1.18% 29
2015
Q2 		$680K Buy
6,976
+936
+15% +$93.7K 0.81% 43
2015
Q1 		$608K Buy
6,040
+185
+3% +$18.8K 0.68% 51
2014
Q4 		$612K Buy
5,855
+1,054
+22% +$111K 0.7% 53
2014
Q3 		$512K Buy
4,801
+1
+0% +$104 0.59% 71
2014
Q2 		$502K Buy
4,800
+1
+0% +$101 0.55% 74
2014
Q1 		$471K Sell
4,799
-179
-4% -$16.6K 0.56% 73
2013
Q4 		$456K Sell
4,978
-393
-7% -$36.2K 0.57% 67
2013
Q3 		$466K Sell
5,371
-256
-5% -$23K 0.64% 68
2013
Q2 		$483K Buy
+5,627
New +$478K 0.69% 66

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IMS Capital Management's JNJ Position: Q3 2025 in Review

IMS Capital Management reduced its Johnson & Johnson (JNJ) stake by 12% in Q3 2025, selling an estimated $276K and leaving 12,008 shares worth $2.23M. The position accounts for 1.03% of the portfolio, ranked #24.

IMS Capital Management first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.28M in Q1 2025. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • IMS Capital Management held 12,008 shares of Johnson & Johnson worth $2.23M as of Q3 2025.
  • IMS Capital Management sold 1,613 Johnson & Johnson shares in Q3 2025, an estimated $276K.
  • Johnson & Johnson made up 1.03% of IMS Capital Management's portfolio in Q3 2025, its #24 holding.
  • IMS Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • IMS Capital Management's Johnson & Johnson position peaked at $3.28M in Q1 2025.
  • 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.